Akèy › Manosidoz Alfa
Etid klinik pou Manosidoz Alfa ap rekrite nan Etazini
5 etid pou Manosidoz Alfa ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
Ap rekriteFaz 1
1 Week – 22 Years · Tout sèks · Mizajou Sep 3, 2026 · NCT02254863Longitudinal Study of Neurodegenerative Disorders
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Feb 9, 2026 · NCT03333200Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Ap rekriteEtid obsèvasyon
2 Months – 60 Years · Tout sèks · Mizajou Jan 13, 2026 · NCT04528355Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Ap rekriteFaz 2
2 Months – 55 Years · Tout sèks · Mizajou Dec 15, 2025 · NCT01962415Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age 3
Ap rekriteEtid obsèvasyon
Jiska laj 3 · Tout sèks · Mizajou May 16, 2025 · NCT06184503Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.